Tumor Liquid Biopsy Kit Market: Will Blood-Based Testing Replace Traditional Cancer Biopsies?
Diagnostic innovation is accelerating as the Tumor Liquid Biopsy Kit Market enables cancer detection and monitoring through minimally invasive blood testing rather than surgical tissue sampling. Liquid biopsy analyzes circulating tumor DNA and cancer biomarkers released into the bloodstream, allowing clinicians to track disease progression in real time.
Unlike conventional biopsies performed...
0 Comments
0 Shares
724 Views